Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
29 Oct 2014 Hormone Therapy Adherence in Early-Stage Breast Cancer Breast cancer - Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
28 Oct 2014 EMA Adopts a Positive Opinion for a New Indication for Enzalutamide Genitourinary cancers - Anticancer agents & Biologic therapy
27 Oct 2014 EMA Recommends Granting a Marketing Authorisation for Olaparib Gynaecologic malignancies - Anticancer agents & Biologic therapy
22 Oct 2014 New Safety Labelling Changes Approved By FDA Center for Drug Evaluation and Research Anticancer agents & Biologic therapy
20 Oct 2014 Information on Suspected Side Effects of EU Nationally Authorised Medicines Now Available Through a Single Website Bioethics, legal and economic issues
17 Oct 2014 EMA Adopts Landmark Policy on Publication of Clinical Reports Bioethics, legal and economic issues
15 Oct 2014 Harnessing 3D Imagery for Early Tumour Detection Imaging
14 Oct 2014 EMA’s Pharmacovigilance Risk Assessment Committee Recommends Further Measures to Minimise Risk of Thrombosis and Occlusion of Blood Vessels With Ponatinib Haematologic malignancies - Anticancer agents & Biologic therapy
13 Oct 2014 FDA Approves an Oral Combination of Netupitant and Palonosetron for Nausea and Vomiting Associated With Cancer Chemotherapy Palliative and supportive care
09 Oct 2014 New Study Finds Lack of Adherence to Safe Handling Guidelines for Administration of Antineoplastic Drugs Anticancer agents & Biologic therapy
08 Oct 2014 European Medicines Agency Adopts a Final Negative Opinion for an Extension of Indications for Bevacizumab Central nervous system malignancies - Anticancer agents & Biologic therapy
07 Oct 2014 FDA Expands Approved Use of Ibrutinib for Chronic Lymphocytic Leukaemia Haematologic malignancies - Anticancer agents & Biologic therapy
06 Oct 2014 ESMO 2014: New Data on First- and Second-Line ALK Inhibition in NSCLC Patients Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
03 Oct 2014 European Medicines Agency Refuses a Change to the Marketing Authorisation for Vinflunine Anticancer agents & Biologic therapy
02 Oct 2014 Rare Cancers Europe Press Release: Specific Clinical Trial Methodology Needed for Rare Cancers